Key result
Comprehensive invasive physiological assessment in the catheterization laboratory allows differentiation between epicardial disease, coronary microvascular dysfunction, and vasomotor impairment to guide targeted therapy.
Why the study?
Up to 40% of patients referred for coronary angiography have no obstructive CAD, and INOCA has typically been underestimated because its prognostic significance was previously unclear.
Integrating invasive physiological assessment with provocative testing is pivotal for correctly diagnosing the underlying mechanisms of myocardial ischemia and tailoring targeted therapies.
Ischemic heart disease is currently the most common cause of mortality and morbidity worldwide. Although myocardial ischemia is classically determined by epicardial coronary atherosclerosis, up to 40% of patients referred for coronary angiography have no obstructive coronary artery disease (CAD). Ischemia with non-obstructive coronary artery disease (INOCA) has typically been underestimated in the past because, until recently, its prognostic significance was not completely clear. This review aims to highlight differences and patterns in myocardial ischemia caused by epicardial obstructive CAD, coronary microvascular dysfunction (CMD) or vasomotor abnormalities and to elucidate the state of the art in correctly diagnosing these different patterns.
No takes yet. Share an insight, caveat, or question.
Monizzi et al. (2024) conducted a review in Ischemic heart disease, including Ischemia with non-obstructive coronary artery disease (INOCA). Invasive physiological assessment of coronary circulation (FFR, NHPR, CFR, IMR, and provocative testing) was evaluated. Comprehensive invasive physiological assessment in the catheterization laboratory allows differentiation between epicardial disease, coronary microvascular dysfunction, and vasomotor impairment to guide targeted therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: